# Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy

> **NCT04970121** · PHASE2 · RECRUITING · sponsor: **Yan Yang, MD, Ph.D** · enrollment: 100 (estimated)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy
- Pain
- Solid Tumor

## Interventions

- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT04970121
- **Lead sponsor:** Yan Yang, MD, Ph.D
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-21
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04970121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04970121, "Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04970121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*